Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · IEX Real-Time Price · USD

2.610

-0.090 (-3.33%)

At close: Jul 19, 2024, 4:00 PM

2.600

-0.010 (-0.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Nautilus Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	25.73	19.4	114.52	185.62	36.61	0.6
Short-Term Investments	155.64	154.02	69.95	160.11	40.14	16.06
Cash & Cash Equivalents	181.37	173.42	184.47	345.73	76.74	16.66
Cash Growth	8.38%	-5.99%	-46.64%	350.51%	360.66%	-
Other Current Assets	3.73	3.42	2.74	3.49	0.92	0.31
Total Current Assets	185.09	176.84	187.21	349.22	77.66	16.96
Property, Plant & Equipment	36.08	36.9	32.57	31.86	6.21	1.12
Long-Term Investments	66.29	90.65	129.17	16.37	0	0
Other Long-Term Assets	1.18	1.18	1.11	1	1.14	0.46
Total Long-Term Assets	103.56	128.73	162.84	49.23	7.35	1.58
Total Assets	288.65	305.57	350.05	398.45	85.01	18.54
Accounts Payable	1.86	1.64	1.27	1.72	0.47	0.29
Current Debt	3.68	3.54	1.99	0.97	1.48	0
Other Current Liabilities	3.68	3.95	3.53	3.12	1.07	0.2
Total Current Liabilities	9.21	9.12	6.79	5.81	3.02	0.49
Long-Term Debt	29.95	31.09	28.34	29.06	3.3	0
Total Long-Term Liabilities	29.95	31.09	28.34	29.06	3.3	0
Total Liabilities	39.16	40.21	35.13	34.87	6.31	0.49
Total Debt	33.62	34.63	30.33	30.03	4.78	0
Debt Growth	-9.89%	14.18%	0.99%	528.94%	-	-
Retained Earnings	-220.97	-202.24	-138.56	-80.64	-30.33	-14.71
Comprehensive Income	-0.75	-0.26	-1.85	-0.18	0	0.01
Shareholders' Equity	249.49	265.35	314.92	363.58	-29.72	-14.51
Net Cash / Debt	147.75	138.79	154.14	315.7	71.97	16.66
Net Cash / Debt Growth	13.62%	-9.96%	-51.17%	338.67%	332.00%	-
Net Cash Per Share	1.18	1.11	1.24	3.74	2.47	2.75
Working Capital	175.88	167.72	180.42	343.41	74.64	16.47
Book Value Per Share	1.99	2.12	2.53	4.30	-1.02	-2.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).